ABOUT OPANA 10MG USA

The concomitant use of OXYCONTIN and CYP3A4 inducers can decrease the plasma concentration of oxycodone [see Scientific PHARMACOLOGY], leading to decreased efficacy or onset of a withdrawal syndrome in patients who definitely have formulated physical dependence to oxycodone [see WARNINGS AND Safeguards].When OXYCONTIN therapy is initiated, disconti